Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
66 participants
INTERVENTIONAL
2012-12-06
2015-12-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pulpotomy in Primary Molars Treated With Premixed Bio-ceramic MTA Versus Formocresol
NCT05314842
MTA/FS Pulpotomy for Vital Primary Incisors: A Randomized Controlled Trial
NCT02019563
Bioactive Materials in Pulp Therapy of Primary Teeth
NCT04795830
Apexification Treatment With MTA(Mineral Trioxide Aggregate) and Ca(OH)2
NCT03855501
Pulpotomy Medications in Primary Teeth
NCT05300152
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Revascularization
Blood clot initiation and grey MTA ( Mineral Tri-oxide Aggregate) cervically compacted.
revascularization
a sterile sharp needle was used to irritate the apical tissue until bleeding occurred apically in the root canal space so as to create a biological scaffold for the regenerative process
Apexfication
Apexification using grey MTA apically compacted without mechanical preparation.
Apexification
a 3-5 mm thickness of MTA using a hand plugger and was verified radiographically.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
revascularization
a sterile sharp needle was used to irritate the apical tissue until bleeding occurred apically in the root canal space so as to create a biological scaffold for the regenerative process
Apexification
a 3-5 mm thickness of MTA using a hand plugger and was verified radiographically.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with systemic diseases e.g. Diabetes mellitus, bleeding disorders,…
* Psychological disturbance
* External / internal root resorption or cystic lesion.
7 Years
16 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Enas Ebrahim Sayed
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Enas Ebrahim Sayed
Dentist at ministry of health
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ahmed alkhadem, lecturer
Role: PRINCIPAL_INVESTIGATOR
evidence based center, Cairo University
References
Explore related publications, articles, or registry entries linked to this study.
Saoud TM, Zaazou A, Nabil A, Moussa S, Lin LM, Gibbs JL. Clinical and radiographic outcomes of traumatized immature permanent necrotic teeth after revascularization/revitalization therapy. J Endod. 2014 Dec;40(12):1946-52. doi: 10.1016/j.joen.2014.08.023. Epub 2014 Oct 16.
Alobaid AS, Cortes LM, Lo J, Nguyen TT, Albert J, Abu-Melha AS, Lin LM, Gibbs JL. Radiographic and clinical outcomes of the treatment of immature permanent teeth by revascularization or apexification: a pilot retrospective cohort study. J Endod. 2014 Aug;40(8):1063-70. doi: 10.1016/j.joen.2014.02.016. Epub 2014 Jun 13.
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
cebd
Identifier Type: OTHER
Identifier Source: secondary_id
Revas1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.